A glycan gate controls opening of the SARS-CoV-2 spike protein

Mostrar otras versiones (1)

SARS-CoV-2 infection is controlled by the opening of the spike protein receptor binding domain (RBD), which transitions from a glycan-shielded “down” to an exposed “up” state in order to bind the human ACE2 receptor and infect cells. While snapshots of the “up” and “down” states have been obtained b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sztain, Terra, Ahn, Surl-Hee, Bogetti, Anthony T., Casalino, Lorenzo, Goldsmith, Jory A., Seitz, Evan, McCool, Ryan S., Kearns, Fiona L., Acosta-Reyes, Francisco, Maji, Suvrajit, Mashayekhi, Ghoncheh, McCammon, J. Andrew, Ourmazd, Abbas, Frank, Joachim, McLellan, Jason S., Chong, Lillian T., Amaro, Rommie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899456/
https://www.ncbi.nlm.nih.gov/pubmed/33619492
http://dx.doi.org/10.1101/2021.02.15.431212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899456/
https://www.ncbi.nlm.nih.gov/pubmed/33619492
http://dx.doi.org/10.1101/2021.02.15.431212

Ejemplares similares